Stemline Therapeutics

Advertisement

cGxPJobs Banner

Elacestrant Phase 2 Combo Data Shows Strong PFS in ER+ mBC

FLORENCE, Italy and NEW YORK, December 8, 2025 — The Menarini Group and its oncology subsidiary Stemline Therapeutics unveiled...

By cGxPwire Editor
December 9, 2025

Read More

Advertisement

cGxPJobs

Directory